v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
January Public Offering
February Public Offering and Leavitt Private Placement
Common Stock
Common Stock
January Public Offering
Common Stock
February Public Offering and Leavitt Private Placement
Additional Paid-in Capital
Additional Paid-in Capital
January Public Offering
Additional Paid-in Capital
February Public Offering and Leavitt Private Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ (77,978)     $ 3     $ 152,596     $ (8,370) $ (222,207)
Beginning Balance (in shares) at Dec. 31, 2024       2,710,607              
Issuance of common stock in connection with vesting of RSU awards (in shares)       3,505              
Issuance of common stock in connection with RTW Private Placement, net of issuance costs (in shares)       841,751              
Issuance of common stock in connection with RTW Private Placement, net of issuance costs 2,500           2,500        
Issuance of shares common stock in connection with public offering, net of issuance costs ( in shares)         1,240,000 1,167,686          
Issuance of value common stock in connection with public offering, net of issuance costs   $ 1,263 $ 589   $ 1 $ 1   $ 1,262 $ 588    
Stock-based compensation expense 897           897        
Other comprehensive income 4,440                 4,440  
Net loss (1,501)                   (1,501)
Ending Balance at Mar. 31, 2025 (69,790)     $ 5     157,843     (3,930) (223,708)
Ending Balance (in shares) at Mar. 31, 2025       5,963,549              
Beginning Balance at Dec. 31, 2025 (77,189)     $ 6     168,627     5,140 (250,962)
Beginning Balance (in shares) at Dec. 31, 2025       12,279,181              
Issuance of common stock to consultants (in shares)       55,740              
Issuance of common stock to consultant 135           135        
Warrant Inducement (in shares)       2,659,565              
Warrant Inducement 3,611           3,611        
Stock-based compensation expense 638           638        
Other comprehensive income 990                 990  
Net loss (6,095)                   (6,095)
Ending Balance at Mar. 31, 2026 $ (77,910)     $ 6     $ 173,011     $ 6,130 $ (257,057)
Ending Balance (in shares) at Mar. 31, 2026       14,994,486